4//SEC Filing
GRAINGER DAVID J 4
Accession 0000899243-21-042447
CIK 0001847903other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 7:00 PM ET
Size
6.0 KB
Accession
0000899243-21-042447
Insider Transaction Report
Form 4
GRAINGER DAVID J
Chief Innovation Officer
Transactions
- Award
Share Option (right to buy)
2021-11-01+175,000→ 175,000 totalExercise: $14.01Exp: 2031-11-01→ Ordinary Shares (175,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to such option shall vest and become exercisable on November 1, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001887115
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 7:00 PM ET
- Size
- 6.0 KB